| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.41T | 1.36T | 1.31T | 1.33T | 1.13T |
| Gross Profit | 500.75B | 493.03B | 456.67B | 466.65B | 418.45B |
| EBITDA | 161.21B | 138.33B | 126.39B | 158.09B | 147.83B |
| Net Income | 18.20B | 55.18B | 52.62B | 75.04B | 92.29B |
Balance Sheet | |||||
| Total Assets | 1.53T | 1.46T | 1.41T | 1.34T | 1.27T |
| Cash, Cash Equivalents and Short-Term Investments | 288.58B | 267.00B | 328.48B | 267.38B | 335.24B |
| Total Debt | 231.46B | 154.72B | 185.20B | 203.29B | 225.15B |
| Total Liabilities | 681.22B | 651.57B | 601.96B | 614.10B | 600.68B |
| Stockholders Equity | 853.50B | 804.75B | 810.99B | 727.35B | 665.63B |
Cash Flow | |||||
| Free Cash Flow | 57.76B | 78.71B | 116.00B | 10.76B | 72.20B |
| Operating Cash Flow | 112.37B | 138.07B | 165.57B | 61.31B | 110.80B |
| Investing Cash Flow | -65.56B | -150.79B | -58.98B | -61.60B | -44.08B |
| Financing Cash Flow | -39.60B | -45.13B | -65.39B | -79.35B | -51.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ¥90.15B | 11.91 | ― | 4.76% | 0.92% | 35.32% | |
66 Neutral | ¥64.62B | 13.85 | ― | 4.01% | 0.34% | 9.38% | |
64 Neutral | ¥781.60B | -8.91 | 6.07% | 3.69% | 3.69% | -66.27% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥3.92T | 19.73 | ― | 3.27% | 1.75% | 93.78% | |
55 Neutral | ¥170.33B | 33.83 | -6.21% | 1.61% | -4.44% | -117.21% |